Welcome to our dedicated page for Ascend Wellness SEC filings (Ticker: AAWH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to decode how federal prohibition, Section 280E taxes, or new state licenses affect Ascend Wellness’s balance sheet? You are not alone—this multi-state operator’s disclosures weave cannabis-specific regulations into hundreds of pages of GAAP language. Stock Titan’s AI turns those dense paragraphs into clear answers in seconds.
Our real-time portal streams every Ascend Wellness SEC filing the moment it hits EDGAR—including the 10-K annual report, each 10-Q quarterly earnings report, and every 8-K material event. Click any document to see an AI summary that highlights state-level revenue, cultivation capacity, and licensing risks, so you can focus on decisions, not page counts.
Need to follow executive moves? We track Ascend Wellness insider trading Form 4 transactions and send alerts on Ascend Wellness Form 4 insider transactions real-time. Investors often ask, “Where can I find the proxy statement executive compensation data?”—it’s here, with context on dilution and performance metrics. Curious about expansion news? “Ascend Wellness 8-K material events explained” appears beside each filing so you grasp the implications instantly.
- “Ascend Wellness quarterly earnings report 10-Q filing” AI-driven trend charts
- “Ascend Wellness annual report 10-K simplified” risk-factor breakdowns
- “Ascend Wellness executive stock transactions Form 4” visualized
- “Understanding Ascend Wellness SEC documents with AI” step-by-step guides
- “Ascend Wellness earnings report filing analysis” ready for export
Whether you are screening license-driven revenue bumps or modeling cash needs under federal reform, our platform provides comprehensive coverage, expert context, and time-saving clarity. Stop combing through PDFs—start uncovering insights.
Ascend Wellness Holdings (AAWH) reported softer results for the quarter ended September 30, 2025. Revenue was $124.7 million, down from $141.6 million a year ago, as both retail and third‑party wholesale sales declined. Gross profit held roughly steady, but operating expenses kept the business near break‑even at the operating line, and interest expense weighed on results. The company posted a net loss of $25.8 million, versus a $28.3 million loss last year.
For the first nine months of 2025, revenue totaled $380.0 million with a net loss of $69.5 million. AAWH ended the quarter with cash of $87.3 million, long‑term debt of $343.7 million, and stockholders’ equity of $2.6 million. Management disclosed indicators raising substantial doubt about going concern, but said this was alleviated by cash on hand and $21.7 million of net cash provided by operating activities year‑to‑date. The company completed several tuck‑in transactions for dispensaries and licenses during 2025. As of November 6, 2025, Class A shares outstanding were 202,269,004, with 65,000 Class B shares.
Ascend Wellness Holdings (AAWH) furnished quarterly results. The company reported that it issued a press release announcing financial results for the quarter ended September 30, 2025, and furnished it as Exhibit 99.1 to an 8-K.
The information was provided under Item 2.02 and is designated as “furnished,” not “filed,” which limits its use under the Exchange Act. The press release is dated November 10, 2025, and the 8-K was signed by Chief Financial Officer Roman Nemchenko.
FAQ
What is the current stock price of Ascend Wellness (AAWH)?
What is the market cap of Ascend Wellness (AAWH)?
